Arbutus Biopharma Corpora...

NASDAQ: ABUS · Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT

Arbutus Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-54.25M -76.57M -69.92M -76.7M -77.09M -74.39M -72.85M -75.47M -72.93M -70.03M -69.46M -68.84M -70.44M -75.63M -76.25M -71.97M -71.56M -66.27M
Depreciation & Amortization
1.01M 1.35M 1.38M 1.41M 1.44M 1.43M 1.4M 1.35M 1.33M 1.37M 1.43M 1.55M 1.65M 1.7M 1.75M 1.81M 1.86M 1.92M
Stock-Based Compensation
8.22M 10.54M 8.99M 9.08M 9.4M 9.18M 9.3M 9.24M 8.48M 7.58M 7.18M 6.95M 6.85M 6.53M 6.42M 6.42M 6.5M 6.35M
Other Working Capital
969.08K 500.78K 531.78K 749.15K -3.98M -6.53M -10.71M -12.22M -9.73M -17.42M 24.48M 25.45M 28.2M 41.54M 3.31M 2.02M 646K 674K
Other Non-Cash Items
-17.71M 1.34M 3.55M 3.83M 4.38M 3.24M -2.03M -3.34M -4.66M -4.36M -3.75M -4.6M -3.06M -1.81M -1.39M -430K 311K 481K
Deferred Income Tax
n/a n/a n/a -1.5M -2.17M -2.71M -2.71M -1.21M -534K n/a n/a 241K 497K 791K 994K 781K 3.1M 2.89M
Change in Working Capital
2.54M 5.3M -2.83M -864.36K -1.75M -8.51M -17.99M -16.21M -14.22M -17.83M 29.24M 26.74M 29.19M 39.39M 930K 441K 724K 749K
Operating Cash Flow
-60.19M -58.71M -64.61M -70.52M -71.57M -76.86M -84.87M -85.63M -82.54M -83.28M -35.36M -37.97M -35.32M -29.03M -67.53M -62.94M -59.08M -53.87M
Capital Expenditures
-86K -86.32K -181.32K -81.96K -113.96K -972.64K -994.64K -1.14M -1.2M -554K -512K -436K -365K -785K -809K -903K -894K -328K
Cash Acquisitions
-37.19M -37.19M n/a -265.1 37.21M 34.91M -2.55M -2.57M -2.59M -268K -1.76M 70.65K 70.92K 51K -18.28M -19.65M -19.65M -19.65M
Purchase of Investments
47.37M 258K -35.77M -15.63M -87.71M -84.73M -79.54M -69.65M -95.22M -88.65M -130.43M -145.33M -112.69M -142.17M -82.22M -110.83M -113.81M -63.24M
Sales Maturities Of Investments
-22.35M 19.5M 56.69M 44.69M 141.25M 130.9M 130.71M 112.03M 113.5M 91M 56M 50M 47M 52M 70.35M 57.2M 60.8M 71.78M
Other Investing Acitivies
40.64M 49.69M 49.43M 49.44M 10.19M 2.76M 2.57M 2.57M 2.57M 268K 1.76M -50.65K 15.94M -22.18M -3.84M -2.47M -20.96M 40.59M
Investing Cash Flow
28.39M 22.45M 22.8M 31.03M 53.45M 45.21M 50.19M 41.23M 17.06M 1.79M -74.94M -95.75M -66.04M -90.95M -12.68M -54.53M -56.41M 5.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -12.14M -12.14M -12.14M -15.35M -15.34M -15.34M -15.34M
Other Financial Acitivies
6.43M 6.33M 6.21M 4.74M 3.25M 2.9M 795K 841K 715K 828K 11.49M 23.51M 25.57M 25.47M 17.92M 18.05M 16.17M 16.07M
Financial Cash Flow
6.43M 30M 51.65M 53.65M 53.55M 34.27M 30.26M 37.92M 45.38M 40.75M 31.81M 79.85M 117.67M 121.85M 137.24M 98.33M 100.47M 101.14M
Net Cash Flow
-25.38M -6.03M 10.04M 14.31M 35.59M 2.53M -4.49M -6.47M -20.12M -40.76M -78.51M -53.88M 16.37M 1.91M 57.03M -19.04M -14.95M 53.01M
Free Cash Flow
-60.28M -58.79M -64.79M -70.6M -71.68M -77.84M -85.86M -86.78M -83.74M -83.83M -35.87M -38.41M -35.68M -29.82M -68.34M -63.84M -59.97M -54.2M